Common reported effects in clinical use include mild injection site reactions with subcutaneous administration, occasional digestive changes when taken orally, and rare reports of fatigue or dizziness
While other atypical Parkinsons syndromes (APS), such as PSP, multisystemic atrophy (MSA), and corticobasal ganglion syndrome (CBS), are characterized by a marked increase in NfL level of CSF due to myelin axonal involvement, this pathological process is not typical in the early stages of PD (von Widekind et al., 2020)
2014 Nov 20;9(11):e110598
Reinforcing this notion, Hossain et al
When tailored appropriately to the individuals clinical status, capacity, and goals, RT serves as an important element alongside aerobic exercise for management of chronic disease
Dosing & Reconstitution Guide Subcutaneous, once weekly Standard / Gradual Approach (2 mL = 7.5 mg/mL) Frequency: Inject once weekly subcutaneously on the same day each week [1] [5]